论文标题: Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma
DOI: 10.20892/j.issn.2095-3941.2020.0186
发表时间: 2021-02-15
期刊: Cancer Biology & Medicine
影响因子: 4.248
原文链接: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877181/